文献

J-GLOBAL ID：200902271612539141   整理番号：06A0455121

危険因子累積は非弁膜性心房細動をもつ患者の血栓塞栓症の危険を増大させる

Accumulation of Risk Factors Increases Risk of Thromboembolic Events in Patients With Nonvalvular Atrial Fibrillation

著者 (9件)： INOUE Hiroshi (Second Dep. of Internal Medicine, Univ. of Toyama) ,  NOZAWA Takashi (Second Dep. of Internal Medicine, Univ. of Toyama) ,  HIRAI Tadakazu (Second Dep. of Internal Medicine, Univ. of Toyama) ,  IWASA Atsushi (Second Dep. of Internal Medicine, Hirosaki Univ.) ,  OKUMURA Ken (Second Dep. of Internal Medicine, Hirosaki Univ.) ,  LEE Jong-dae (First Dep. of Internal Medicine, Fukui Univ.) ,  SHIMIZU Akihiko (Fac. of Health Sci., Yamaguchi Univ. School of Medicine) ,  HAYANO Motonobu (Third Dep. of Internal Medicine, Nagasaki Univ.) ,  YANO Katsusuke (Third Dep. of Internal Medicine, Nagasaki Univ.)
資料名： Circulation Journal  (Circulation Journal)
巻： 70  号： 6  ページ： 651-656 (J-STAGE)  発行年： 2006年 
JST資料番号： F0908A  ISSN： 1346-9843  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： 背景:危険因子の累積は非弁膜性心房細動(NVAF)患者の血栓...

シソーラス用語： 危険因子 ,...

   続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=06A0455121&from=J-GLOBAL&jstjournalNo=F0908A") }}

分類 (1件)： 循環系の疾患  (GJ03000C)

物質索引 (3件)： アスピリン ,  チクロピジン ,  ワルファリン

引用文献 (15件)：

• 1. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994; 154: 1449-1457.
• 2. Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Circulation 2001; 104: 2118-2150.
• 3. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: Results from the national registry of atrial fibrillation. JAMA 2001; 285: 2864-2870.
• 4. Yasaka M, Minematsu K, Yamaguchi T. Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation. Intern Med 2001; 40: 1183-1188.
• 5. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, et al for the Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002; 347: 1834-1840.

タイトルに関連する用語 (5件)： 危険因子 ,  累積 ,  非弁膜性心房細動 ,  患者 ,  血栓塞栓症